Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients
Titel:
Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients
Auteur:
Ewijk, R. Van Wöckel, A. Gundelach, T. Hancke, K. Janni, W. Singer, S. Kreienberg, R. Blettner, M. Schwentner, L.